BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Scheiblauer H, El-Nageh M, Diaz S, Nick S, Zeichhardt H, Grunert HP, Prince A. Performance evaluation of 70 hepatitis B virus (HBV) surface antigen (HBsAg) assays from around the world by a geographically diverse panel with an array of HBV genotypes and HBsAg subtypes. Vox Sang. 2010;98:403-414. [PMID: 20412171 DOI: 10.1111/j.1423-0410.2009.01272.x] [Cited by in Crossref: 87] [Cited by in F6Publishing: 79] [Article Influence: 6.7] [Reference Citation Analysis]
Number Citing Articles
1 Pondé RAA. The serological markers of acute infection with hepatitis A, B, C, D, E and G viruses revisited. Arch Virol 2017;162:3587-602. [PMID: 28884240 DOI: 10.1007/s00705-017-3538-3] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
2 Pruett CR, Vermeulen M, Zacharias P, Ingram C, Tayou Tagny C, Bloch EM. The use of rapid diagnostic tests for transfusion infectious screening in Africa: a literature review. Transfus Med Rev 2015;29:35-44. [PMID: 25447555 DOI: 10.1016/j.tmrv.2014.09.003] [Cited by in Crossref: 30] [Cited by in F6Publishing: 26] [Article Influence: 3.8] [Reference Citation Analysis]
3 Tuaillon E, Kania D, Pisoni A, Bollore K, Taieb F, Ontsira Ngoyi EN, Schaub R, Plantier JC, Makinson A, Van de Perre P. Dried Blood Spot Tests for the Diagnosis and Therapeutic Monitoring of HIV and Viral Hepatitis B and C. Front Microbiol 2020;11:373. [PMID: 32210946 DOI: 10.3389/fmicb.2020.00373] [Cited by in Crossref: 17] [Cited by in F6Publishing: 12] [Article Influence: 8.5] [Reference Citation Analysis]
4 Hønge B, Jespersen S, Medina C, Té D, da Silva Z, Ostergaard L, Laursen A, Wejse C, Krarup H, Erikstrup C; Bissau HIV cohort study group. Hepatitis B virus surface antigen and anti-hepatitis C virus rapid tests underestimate hepatitis prevalence among HIV-infected patients. HIV Med 2014;15:571-6. [PMID: 24717010 DOI: 10.1111/hiv.12158] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 1.4] [Reference Citation Analysis]
5 Chisenga CC, Musukuma K, Chilengi R, Zürcher S, Munamunungu V, Siyunda A, Ojok D, Bauer S, Wandeler G, Vinikoor M; for International Epidemiological Databases to Evaluate AIDS in Southern Africa (IeDEA-SA) Institutions. Field performance of the Determine HBsAg point-of-care test for diagnosis of hepatitis B virus co-infection among HIV patients in Zambia. J Clin Virol 2018;98:5-7. [PMID: 29175231 DOI: 10.1016/j.jcv.2017.11.005] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 2.2] [Reference Citation Analysis]
6 Villar LM, Cruz HM, Barbosa JR, Bezerra CS, Portilho MM, Scalioni LP. Update on hepatitis B and C virus diagnosis. World J Virology 2015; 4(4): 323-342 [PMID: 26568915 DOI: 10.5501/wjv.v4.i4.323] [Cited by in CrossRef: 42] [Cited by in F6Publishing: 40] [Article Influence: 6.0] [Reference Citation Analysis]
7 Skaletz-rorowski A, Mau M, Brockmeyer NH. Schnelltests in der STI-Diagnostik. gynäkologie + geburtshilfe 2019;24:17-20. [DOI: 10.1007/s15013-019-1642-z] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
8 Martin LA, Stramer SL, Kuhns MC, Schlauder GG. Correlation of improved hepatitis B surface antigen detection limits with hepatitis B virus DNA nucleic acid test yield in blood donations: CORRELATE HBsAg DETECTION LIMIT WITH NAT. Transfusion 2012;52:2201-8. [DOI: 10.1111/j.1537-2995.2011.03553.x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
9 Seri B, Minga A, Gabillard D, Dembele B, Konate S, Le Carrou J, Dohoun L, Abo Y, Karcher S, Coffie P, N'Dri-Yoman T, Attia A, Eholié SP, Danel C, Lacombe K, Anglaret X, Boyd A. Twenty-Year Evolution of Hepatitis B Virus and Human Immunodeficiency Virus Prevalence and Incidence in Voluntary Blood Donors in Côte d'Ivoire. Open Forum Infect Dis 2018;5:ofy060. [PMID: 29644251 DOI: 10.1093/ofid/ofy060] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
10 Candotti D, Tagny-Tayou C, Laperche S. Challenges in transfusion-transmitted infection screening in Sub-Saharan Africa. Transfus Clin Biol 2021;28:163-70. [PMID: 33515730 DOI: 10.1016/j.tracli.2021.01.007] [Reference Citation Analysis]
11 Devine A, Harvey R, Min AM, Gilder MET, Paw MK, Kang J, Watts I, Hanboonkunupakarn B, Nosten F, McGready R. Strategies for the prevention of perinatal hepatitis B transmission in a marginalized population on the Thailand-Myanmar border: a cost-effectiveness analysis. BMC Infect Dis 2017;17:552. [PMID: 28793866 DOI: 10.1186/s12879-017-2660-x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
12 Kamat SP, Mehta PR, Paranjpe SM, Ingole NA. Hepatitis B Virus (HBV) Infection in Liver Disease Patients in Mumbai, India with Special Reference to Hepatitis B Surface Antigen (HBsAg) Mutant Detection. J Clin Diagn Res 2014;8:19-21. [PMID: 24783069 DOI: 10.7860/JCDR/2014/7202.4093] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
13 Malecki M, Sabo C, Foorohar A, Tombokan X. Novel paradigm for immunotherapy of breast cancer by engaging prophylactic immunity against hepatitis B. Clin Transl Med 2016;5:32. [PMID: 27539579 DOI: 10.1186/s40169-016-0111-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
14 Arcot PJ, Pandey HC, Coshic P, Jain P, Kumar S, Chakroborty S. Comparative evaluation of ADVIA Centaur® XP chemiluminescence system for screening of HBV, HCV, HIV and syphilis in Indian blood donors. Transfus Apher Sci 2021;:103318. [PMID: 34782243 DOI: 10.1016/j.transci.2021.103318] [Reference Citation Analysis]
15 De A, Roy S, Sukla S, Ansari A, Biswas S. Occult Hepatitis B Virus Infections (Often with Human Herpesvirus 7 Co-Infection) Detected in Pityriasis rosea Patients: A Pilot Study. Indian J Dermatol. 2017;62:598-605. [PMID: 29263533 DOI: 10.4103/ijd.ijd_235_17] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
16 Coffin CS, Zhou K, Terrault NA. New and Old Biomarkers for Diagnosis and Management of Chronic Hepatitis B Virus Infection. Gastroenterology 2019;156:355-368.e3. [PMID: 30472225 DOI: 10.1053/j.gastro.2018.11.037] [Cited by in Crossref: 35] [Cited by in F6Publishing: 34] [Article Influence: 8.8] [Reference Citation Analysis]
17 Ansumana R, Dariano DF 3rd, Jacobsen KH, Leski TA, Lamin JM, Lahai J, Bangura U, Bockarie AS, Taitt CR, Yasuda C, Bockarie MJ, Stenger DA. Seroprevalence of hepatitis B surface antigen (HBsAg) in Bo, Sierra Leone, 2012-2013. BMC Res Notes 2018;11:113. [PMID: 29422083 DOI: 10.1186/s13104-018-3218-8] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
18 Pang Y, Kartsonaki C, Turnbull I, Guo Y, Clarke R, Chen Y, Bragg F, Yang L, Bian Z, Millwood IY, Hao J, Han X, Zang Y, Chen J, Li L, Holmes MV, Chen Z. Diabetes, Plasma Glucose, and Incidence of Fatty Liver, Cirrhosis, and Liver Cancer: A Prospective Study of 0.5 Million People. Hepatology. 2018;68:1308-1318. [PMID: 29734463 DOI: 10.1002/hep.30083] [Cited by in Crossref: 49] [Cited by in F6Publishing: 52] [Article Influence: 16.3] [Reference Citation Analysis]
19 Dembele B, Affi-Aboli R, Kabran M, Sevede D, Goha V, Adiko AC, Kouamé R, Allah-Kouadio E, Inwoley A. Evaluation of Four Rapid Tests for Detection of Hepatitis B Surface Antigen in Ivory Coast. J Immunol Res 2020;2020:6315718. [PMID: 32676509 DOI: 10.1155/2020/6315718] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
20 Limeres MJ, Gomez ER, Noseda DG, Cerrudo CS, Ghiringhelli PD, Nusblat AD, Cuestas ML. Impact of hepatitis B virus genotype F on in vitro diagnosis: detection efficiency of HBsAg from Amerindian subgenotypes F1b and F4. Arch Virol 2019;164:2297-307. [PMID: 31267215 DOI: 10.1007/s00705-019-04332-8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
21 Pondé RA. Molecular mechanisms underlying HBsAg negativity in occult HBV infection. Eur J Clin Microbiol Infect Dis. 2015;34:1709-1731. [PMID: 26105620 DOI: 10.1007/s10096-015-2422-x] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 2.4] [Reference Citation Analysis]
22 Golsaz-Shirazi F, Asadi-Asadabad S, Sarvnaz H, Mehdi Amiri M, Hojjat-Farsangi M, Chudy M, Jeddi-Tehrani M, Shokri F. Immunoreactivity pattern of monoclonal antibodies against Hepatitis B vaccine with global Hepatitis B virus genotypes. Clin Chim Acta 2020;510:203-10. [PMID: 32679130 DOI: 10.1016/j.cca.2020.07.026] [Reference Citation Analysis]
23 Xiao Y, Thompson AJ, Howell J. Point-of-Care Tests for Hepatitis B: An Overview. Cells 2020;9:E2233. [PMID: 33023265 DOI: 10.3390/cells9102233] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
24 Avellón A, Echevarría JM, Weber B, Weik M, Schobel U, Willems WR, Gerlich WH. European collaborative evaluation of the enzygnost HBsAg 6.0 assay: Performance on hepatitis B virus surface antigen variants. J Med Virol 2011;83:95-100. [DOI: 10.1002/jmv.21943] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 0.8] [Reference Citation Analysis]
25 Afolabi AY, Bakarey AS, Adewumi MO. Evaluation of performance testing of different rapid diagnostic kits in comparison with EIAs to validate detection of hepatitis B virus among high risk group in Nigeria. J Immunoassay Immunochem 2018;39:218-27. [PMID: 29764292 DOI: 10.1080/15321819.2018.1458238] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
26 Ye Q, Shang SQ, Li W. A new vaccine escape mutant of hepatitis B virus causes occult infection. Hum Vaccin Immunother. 2015;11:407-410. [PMID: 25692622 DOI: 10.4161/21645515.2014.994461] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 2.7] [Reference Citation Analysis]
27 Chevaliez S, Challine D, Naija H, Luu TC, Laperche S, Nadala L, Allain JP, Lee HH, Pawlotsky JM. Performance of a new rapid test for the detection of hepatitis B surface antigen in various patient populations. J Clin Virol. 2014;59:89-93. [PMID: 24355522 DOI: 10.1016/j.jcv.2013.11.010] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 1.7] [Reference Citation Analysis]
28 Larralde O, Dow B, Jarvis L, Davidson F, Petrik J. Hepatitis B escape mutants in Scottish blood donors. Med Microbiol Immunol. 2013;202:207-214. [PMID: 23274404 DOI: 10.1007/s00430-012-0283-9] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.1] [Reference Citation Analysis]
29 Meyer T, Schüttler CG, Straube E, Roß RS, Stürmer M, Jansen K, Buder S, Nick S, Hagedorn H, Bremer V, Brockmeyer NH. Schnelltest-Diagnostik sexuell übertragbarer Infektionen in niedrigschwelligen Einrichtungen: Gemeinsame Stellungnahme des RKI, PEI und der DSTIG. Bundesgesundheitsbl 2017;60:245-54. [DOI: 10.1007/s00103-016-2496-3] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 1.7] [Reference Citation Analysis]
30 Martiskainen I, Talha SM, Vuorenpää K, Salminen T, Juntunen E, Chattopadhyay S, Kumar D, Vuorinen T, Pettersson K, Khanna N, Batra G. Upconverting nanoparticle reporter-based highly sensitive rapid lateral flow immunoassay for hepatitis B virus surface antigen. Anal Bioanal Chem 2021;413:967-78. [PMID: 33230700 DOI: 10.1007/s00216-020-03055-z] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
31 Yildiz UH, Inci F, Wang S, Toy M, Tekin HC, Javaid A, Lau DT, Demirci U. Recent advances in micro/nanotechnologies for global control of hepatitis B infection. Biotechnol Adv 2015;33:178-90. [PMID: 25450190 DOI: 10.1016/j.biotechadv.2014.11.003] [Cited by in Crossref: 30] [Cited by in F6Publishing: 24] [Article Influence: 3.8] [Reference Citation Analysis]
32 Choisy M, Keomalaphet S, Xaydalasouk K, Quet F, Latthaphasavang V, Buisson Y. Prevalence of Hepatitis B Virus Infection among Pregnant Women Attending Antenatal Clinics in Vientiane, Laos, 2008-2014. Hepat Res Treat 2017;2017:1284273. [PMID: 28465839 DOI: 10.1155/2017/1284273] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 1.2] [Reference Citation Analysis]
33 Moura IF, Lopes EP, Alvarado-Mora MV, Pinho JR, Carrilho FJ. Phylogenetic analysis and subgenotypic distribution of the hepatitis B virus in Recife, Brazil. Infect Genet Evol. 2013;14:195-199. [PMID: 23268113 DOI: 10.1016/j.meegid.2012.11.022] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 1.7] [Reference Citation Analysis]
34 de Almeida Pondé RA. Detection of the serological markers hepatitis B virus surface antigen (HBsAg) and hepatitis B core IgM antibody (anti-HBcIgM) in the diagnosis of acute hepatitis B virus infection after recent exposure. Microbiol Immunol 2021. [PMID: 34528725 DOI: 10.1111/1348-0421.12943] [Reference Citation Analysis]
35 Meyer T, Eberle J, Roß RS, Schüttler CG, Baier M, Buder S, Kohl PK, Münstermann D, Hagedorn HJ, Nick S, Jansen K, Bremer V, Mau M, Brockmeyer NH. [Rapid diagnosis of sexually transmitted infections : Joint statement of DSTIG, RKI, and PEI, as well as the reference centers for HIV, HBV, and HCV and consulting laboratories for Chlamydia, gonococci, and Treponema pallidum]. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 2020;63:1271-86. [PMID: 32930821 DOI: 10.1007/s00103-020-03218-4] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
36 Ryu JH, Kwon M, Moon JD, Hwang MW, Lee JM, Park KH, Yun SJ, Bae HJ, Choi A, Lee H, Jung B, Jeong J, Han K, Kim Y, Oh EJ. Development of a Rapid Automated Fluorescent Lateral Flow Immunoassay to Detect Hepatitis B Surface Antigen (HBsAg), Antibody to HBsAg, and Antibody to Hepatitis C. Ann Lab Med 2018;38:578-84. [PMID: 30027702 DOI: 10.3343/alm.2018.38.6.578] [Cited by in F6Publishing: 13] [Reference Citation Analysis]
37 Bivigou-Mboumba B, Amougou-Atsama M, Zoa-Assoumou S, M'boyis Kamdem H, Nzengui-Nzengui GF, Ndojyi-Mbiguino A, Njouom R, François-Souquière S. Hepatitis B infection among HIV infected individuals in Gabon: Occult hepatitis B enhances HBV DNA prevalence. PLoS One 2018;13:e0190592. [PMID: 29315352 DOI: 10.1371/journal.pone.0190592] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
38 Subic M, Zoulim F. How to improve access to therapy in hepatitis B patients. Liver Int 2018;38 Suppl 1:115-21. [PMID: 29427482 DOI: 10.1111/liv.13640] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 4.7] [Reference Citation Analysis]
39 Bragina VA, Orlov AV, Znoyko SL, Pushkarev AV, Novichikhin DO, Guteneva NV, Nikitin MP, Gorshkov BG, Nikitin PI. Nanobiosensing based on optically selected antibodies and superparamagnetic labels for rapid and highly sensitive quantification of polyvalent hepatitis B surface antigen. Anal Methods 2021;13:2424-33. [PMID: 33998615 DOI: 10.1039/d1ay00354b] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
40 Shaha M, Hoque SA, Rahman SR. Molecular epidemiology of hepatitis B virus isolated from Bangladesh. Springerplus 2016;5:1513. [PMID: 27652086 DOI: 10.1186/s40064-016-3174-5] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
41 Pronier C, Candotti D, Boizeau L, Bomo J, Laperche S, Thibault V. The contribution of more sensitive hepatitis B surface antigen assays to detecting and monitoring hepatitis B infection. J Clin Virol 2020;129:104507. [PMID: 32570044 DOI: 10.1016/j.jcv.2020.104507] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
42 Barbosa JR, Colares JKB, Flores GL, Cortes VF, Miguel JC, Portilho MM, Marques VA, Potsch DV, Brandão-Mello CE, Amendola-Pires M, Pilotto JH, Lima DM, Lampe E, Villar LM. Performance of rapid diagnostic tests for detection of Hepatitis B and C markers in HIV infected patients. J Virol Methods 2017;248:244-9. [PMID: 28782578 DOI: 10.1016/j.jviromet.2017.08.001] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 2.6] [Reference Citation Analysis]
43 Hori N, Chikae M, Kirimura H, Takamura Y. Design of dual working electrodes for concentration process in metalloimmunoassay. Biomed Microdevices 2016;18:86. [PMID: 27572238 DOI: 10.1007/s10544-016-0114-7] [Reference Citation Analysis]
44 Jazayeri SM, Alavian SM, Dindoost P, Thomas HC, Karayiannis P. Molecular Variants of Hepatitis B Surface Antigen (HBsAg). In: Thomas HC, Lok AS, Locarnini SA, Zuckerman AJ, editors. Viral Hepatitis. Oxford: John Wiley & Sons, Ltd; 2013. pp. 107-26. [DOI: 10.1002/9781118637272.ch8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
45 Delwart E, Slikas E, Stramer SL, Kamel H, Kessler D, Krysztof D, Tobler LH, Carrick DM, Steele W, Todd D. Genetic diversity of recently acquired and prevalent HIV, hepatitis B virus, and hepatitis C virus infections in US blood donors. J Infect Dis. 2012;205:875-885. [PMID: 22293432 DOI: 10.1093/infdis/jir862] [Cited by in Crossref: 45] [Cited by in F6Publishing: 42] [Article Influence: 4.5] [Reference Citation Analysis]
46 Mbanya D. Use of quality rapid diagnostic testing for safe blood transfusion in resource-limited settings. Clin Microbiol Infect 2013;19:416-21. [PMID: 23464853 DOI: 10.1111/1469-0691.12184] [Cited by in Crossref: 17] [Cited by in F6Publishing: 12] [Article Influence: 1.9] [Reference Citation Analysis]
47 Im PK, Millwood IY, Kartsonaki C, Guo Y, Chen Y, Turnbull I, Yu C, Du H, Pei P, Lv J, Walters RG, Li L, Yang L, Chen Z; China Kadoorie Biobank (CKB) collaborative group. Alcohol drinking and risks of liver cancer and non-neoplastic chronic liver diseases in China: a 10-year prospective study of 0.5 million adults. BMC Med 2021;19:216. [PMID: 34530818 DOI: 10.1186/s12916-021-02079-1] [Reference Citation Analysis]
48 Mitterreiter J, Scheiblauer H, Fiedler S, Kreß J. [Safety of blood and blood products: test methods for the detection of hepatitis B, C, and E virus]. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 2022. [PMID: 35024894 DOI: 10.1007/s00103-021-03480-0] [Reference Citation Analysis]
49 Njai HF, Shimakawa Y, Sanneh B, Ferguson L, Ndow G, Mendy M, Sow A, Lo G, Toure-Kane C, Tanaka J. Validation of rapid point-of-care (POC) tests for detection of hepatitis B surface antigen in field and laboratory settings in the Gambia, Western Africa. J Clin Microbiol. 2015;53:1156-1163. [PMID: 25631805 DOI: 10.1128/jcm.02980-14] [Cited by in Crossref: 61] [Cited by in F6Publishing: 28] [Article Influence: 8.7] [Reference Citation Analysis]
50 Peng J, Cheng L, Yin B, Guan Q, Liu Y, Wu S, Wang B, Tang N, Zhang B, Wang L, Yang D, Sun Z. Development of an economic and efficient strategy to detect HBsAg: Application of “gray-zones” in ELISA and combined use of several detection assays. Clinica Chimica Acta 2011;412:2046-51. [DOI: 10.1016/j.cca.2011.01.020] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
51 Otero MÁ, Liu CH, Ampuero J, Llorca R, Vargas M, Vargas-Romero J, Romero-Gómez M. Peer-to-Peer Sessions in Primary Care to Improve the Hepatitis B Detection Rate in Seville, Spain. Ann Hepatol 2018;17:864-70. [PMID: 30145574 DOI: 10.5604/01.3001.0012.3162] [Reference Citation Analysis]
52 Getahun A, Baekalia M, Panda N, Lee A, Puiahi E, Khan S, Tahani D, Manongi D. Seroprevalence of hepatitis B surface antigen in pregnant women attending antenatal clinic in Honiara Solomon Islands, 2015. World J Hepatol 2016; 8(34): 1521-1528 [PMID: 28008343 DOI: 10.4254/wjh.v8.i34.1521] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
53 Candotti D, Laperche S. Hepatitis B Virus Blood Screening: Need for Reappraisal of Blood Safety Measures? Front Med (Lausanne) 2018;5:29. [PMID: 29515997 DOI: 10.3389/fmed.2018.00029] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 4.8] [Reference Citation Analysis]
54 Jagannathan L, Chaturvedi M, Mudaliar S, Kamaladoss T, Rice M, Murphy EL. Risk factors for chronic hepatitis B virus infection among blood donors in Bangalore, India. Transfus Med 2010;20:414-20. [PMID: 20726953 DOI: 10.1111/j.1365-3148.2010.01032.x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
55 Kweon OJ, Lim YK, Kim HR, Kim TH, Lee MK. Analytical performance of newly developed rapid point-of-care test for the simultaneous detection of hepatitis A, B, and C viruses in serum samples. J Med Virol 2019;91:1056-62. [PMID: 30668895 DOI: 10.1002/jmv.25405] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
56 Laperche S. Multinational assessment of blood-borne virus testing and transfusion safety on the African continent. Transfusion. 2013;53:816-826. [PMID: 22804482 DOI: 10.1111/j.1537-2995.2012.03797.x] [Cited by in Crossref: 39] [Cited by in F6Publishing: 34] [Article Influence: 3.9] [Reference Citation Analysis]
57 Taramasso L, Caligiuri P, Di Biagio A, Bruzzone B, Rosso R, Icardi G, Viscoli C. Lamivudine resistance mutations in European patients with hepatitis B and patients co-infected with HIV and hepatitis B. J Med Virol 2011;83:1905-8. [PMID: 21915864 DOI: 10.1002/jmv.22192] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
58 Alavian SM, Carman WF, Jazayeri SM. HBsAg variants: diagnostic-escape and diagnostic dilemma. J Clin Virol. 2013;57:201-208. [PMID: 22789139 DOI: 10.1016/j.jcv.2012.04.027] [Cited by in Crossref: 54] [Cited by in F6Publishing: 49] [Article Influence: 5.4] [Reference Citation Analysis]
59 Orlien SMS, Ahmed TA, Ismael NY, Berhe Belay N, Kran AB, Gundersen SG, Johannessen A. Field performance of HBsAg rapid diagnostic tests in rural Ethiopia. J Virol Methods 2021;289:114061. [PMID: 33388369 DOI: 10.1016/j.jviromet.2020.114061] [Reference Citation Analysis]
60 Schmidt M, Jimenez A, Mühlbacher A, Oota S, Blanco L, Sakuldamrongpanich T, Schennach H, Seifried E. Head-to-head comparison between two screening systems for HBsAG, anti-HBc, anti-HCV and HIV combination immunoassays in an international, multicentre evaluation study. Vox Sang 2015;109:114-21. [PMID: 25899479 DOI: 10.1111/vox.12259] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
61 Anderson M, Gaseitsiwe S, Moyo S, Wessels MJ, Mohammed T, Sebunya TK, Powell EA, Makhema J, Blackard JT, Marlink R, Essex M, Musonda RM. Molecular characterisation of hepatitis B virus in HIV-1 subtype C infected patients in Botswana. BMC Infect Dis 2015;15:335. [PMID: 26268355 DOI: 10.1186/s12879-015-1096-4] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 1.9] [Reference Citation Analysis]
62 Amini A, Varsaneux O, Kelly H, Tang W, Chen W, Boeras DI, Falconer J, Tucker JD, Chou R, Ishizaki A, Easterbrook P, Peeling RW. Diagnostic accuracy of tests to detect hepatitis B surface antigen: a systematic review of the literature and meta-analysis. BMC Infect Dis 2017;17:698. [PMID: 29143619 DOI: 10.1186/s12879-017-2772-3] [Cited by in Crossref: 52] [Cited by in F6Publishing: 52] [Article Influence: 10.4] [Reference Citation Analysis]
63 Talha SM, Saviranta P, Hattara L, Vuorinen T, Hytönen J, Khanna N, Pettersson K. Array-in-well platform-based multiplex assay for the simultaneous detection of anti-HIV- and treponemal-antibodies, and Hepatitis B surface antigen. J Immunol Methods 2016;429:21-7. [PMID: 26711310 DOI: 10.1016/j.jim.2015.12.007] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
64 Chudy M, Scheiblauer H, Hanschmann KM, Kress J, Nick S, Wend U, Schüttler C, Nübling CM, Gerlich WH. Performance of hepatitis B surface antigen tests with the first WHO international hepatitis B virus genotype reference panel. J Clin Virol. 2013;58:47-53. [PMID: 23829967 DOI: 10.1016/j.jcv.2013.06.011] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 2.3] [Reference Citation Analysis]
65 Hønge BL, Jespersen S, Medina C, Wejse C, Erikstrup C. Comment on Lô et al.: Prevalence of hepatitis B markers in Senegalese HIV-1 infected patients: Comment on Lô et al. J Med Virol 2016;88:1653-4. [DOI: 10.1002/jmv.24455] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
66 Purwono PB, Juniastuti, Amin M, Bramanthi R, Nursidah, Resi EM, Wahyuni RM, Yano Y, Soetjipto, Hotta H, Hayashi Y, Utsumi T, Lusida MI. Hepatitis B Virus Infection in Indonesia 15 Years After Adoption of a Universal Infant Vaccination Program: Possible Impacts of Low Birth Dose Coverage and a Vaccine-Escape Mutant. Am J Trop Med Hyg 2016;95:674-9. [PMID: 27402524 DOI: 10.4269/ajtmh.15-0121] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
67 Levi JE, Pereira RA, Polite MB, Mota MA, Nunez SP, Pinho JR, Kutner JM. One window-period donation in two years of individual donor-nucleic acid test screening for hepatitis B, hepatitis C and human immunodeficiency virus. Rev Bras Hematol Hemoter 2013;35:167-70. [PMID: 23904804 DOI: 10.5581/1516-8484.20130039] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
68 Gish RG, Gutierrez JA, Navarro-Cazarez N, Giang K, Adler D, Tran B, Locarnini S, Hammond R, Bowden S. A simple and inexpensive point-of-care test for hepatitis B surface antigen detection: serological and molecular evaluation. J Viral Hepat 2014;21:905-8. [PMID: 24779356 DOI: 10.1111/jvh.12257] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 2.9] [Reference Citation Analysis]
69 Pujol F, Jaspe RC, Loureiro CL, Chemin I. Hepatitis B virus American genotypes: Pathogenic variants ? Clin Res Hepatol Gastroenterol 2020;44:825-35. [PMID: 32553521 DOI: 10.1016/j.clinre.2020.04.018] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
70 Hassemer M, Finkernagel M, Peiffer KH, Glebe D, Akhras S, Reuter A, Scheiblauer H, Sommer L, Chudy M, Nübling CM, Hildt E. Comparative characterization of hepatitis B virus surface antigen derived from different hepatitis B virus genotypes. Virology 2017;502:1-12. [PMID: 27951436 DOI: 10.1016/j.virol.2016.12.003] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]
71 Talha SM, Salminen T, Juntunen E, Spangar A, Gurramkonda C, Vuorinen T, Khanna N, Pettersson K. Europium nanoparticle-based simple to perform dry-reagent immunoassay for the detection of hepatitis B surface antigen. J Virol Methods 2016;229:66-9. [PMID: 26762619 DOI: 10.1016/j.jviromet.2016.01.001] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
72 Allain J, Opare-sem O. Screening and diagnosis of HBV in low-income and middle-income countries. Nat Rev Gastroenterol Hepatol 2016;13:643-53. [DOI: 10.1038/nrgastro.2016.138] [Cited by in Crossref: 33] [Cited by in F6Publishing: 34] [Article Influence: 5.5] [Reference Citation Analysis]
73 Castilho Mda C, Oliveira CM, Gimaque JB, Leão JD, Braga WS. Epidemiology and molecular characterization of hepatitis B virus infection in isolated villages in the Western Brazilian Amazon. Am J Trop Med Hyg 2012;87:768-74. [PMID: 22908032 DOI: 10.4269/ajtmh.2012.12-0083] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 2.0] [Reference Citation Analysis]
74 Malecki M, Putzer E, Quach C, Dodivenaka C, Tombokan X. Novel paradigm for immunotherapy of ovarian cancer by engaging prophylactic immunity against hepatitis B virus. Clin Transl Med 2016;5:44. [PMID: 27905089 DOI: 10.1186/s40169-016-0125-2] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
75 Lai MW, Lin TY, Liang KH, Lin WR, Yeh CT. Hepatitis B viremia in completely immunized individuals negative for anti-hepatitis B core antibody. Medicine (Baltimore) 2016;95:e5625. [PMID: 27930595 DOI: 10.1097/MD.0000000000005625] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
76 Khuroo MS, Khuroo NS, Khuroo MS. Accuracy of Rapid Point-of-Care Diagnostic Tests for Hepatitis B Surface Antigen-A Systematic Review and Meta-analysis. J Clin Exp Hepatol. 2014;4:226-240. [PMID: 25755565 DOI: 10.1016/j.jceh.2014.07.008] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 3.1] [Reference Citation Analysis]
77 de Almeida Pondé RA. Dynamic profile of the HBeAg-anti-HBe system in acute and chronic hepatitis B virus infection: A clinical-laboratory approach. Mol Biol Rep 2021;48:843-54. [PMID: 33296069 DOI: 10.1007/s11033-020-06056-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
78 Dindoost P, Jazayeri SM, Karimzadeh H, Saberfar E, Miri SM, Alavian SM. HBsAg Variants: Common Escape Issues. Jundishapur J Microbiol 2012;5:521-7. [DOI: 10.5812/jjm.4243] [Cited by in Crossref: 11] [Cited by in F6Publishing: 5] [Article Influence: 1.1] [Reference Citation Analysis]
79 Tuteja A, Siddiqui AB, Madan K, Goyal R, Shalimar V, Kaur N, Panda SK, Narayanasamy K, Subodh S, Acharya SK. Mutation profiling of the hepatitis B virus strains circulating in North Indian population. PLoS One. 2014;9:e91150. [PMID: 24637457 DOI: 10.1371/journal.pone.0091150] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 1.4] [Reference Citation Analysis]
80 Kabamba AT, Mwamba CM, Dessilly G, Dufrasne F, Kabamba BM, Longanga AO. Evaluation of the analytical performance of six rapid diagnostic tests for the detection of viral hepatitis B and C in Lubumbashi, Democratic Republic of Congo. J Virol Methods 2020;285:113961. [PMID: 32860797 DOI: 10.1016/j.jviromet.2020.113961] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
81 Chen SC, Toy M, Yeh JM, Wang JD, Resch S. Cost-effectiveness of augmenting universal hepatitis B vaccination with immunoglobin treatment. Pediatrics. 2013;131:e1135-e1143. [PMID: 23530168 DOI: 10.1542/peds.2012-1262] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 2.8] [Reference Citation Analysis]
82 Boyd A, Maylin S, Moh R, Gabillard D, Menan H, Mahjoub N, Danel C, Anglaret X, Eholié SP, Girard PM, Zoulim F, Delaugerre C, Lacombe K; ANRS 12240 VarBVA study. Identifying patients infected with hepatitis B virus in sub-Saharan Africa: potential for misclassification. Diagn Microbiol Infect Dis 2015;83:248-51. [PMID: 26283522 DOI: 10.1016/j.diagmicrobio.2015.07.009] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
83 Fletcher GJ, Anantharam R, Radhakrishnan K, Singh U, Karunakaran A, Jeyaseelan V, Abraham P. Evaluation of reliability and performance of hepatitis B virus-e-antigen assays in tertiary care setting. J Immunoassay Immunochem 2018;39:622-35. [PMID: 30362912 DOI: 10.1080/15321819.2018.1529680] [Reference Citation Analysis]